Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Womens Health Supplements Market

Womens Health Supplements Market Trends

Report ID: GMI8439
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Women’s Health Supplements Market Trends

The expansion of the elderly female population has propelled the market. Along with age, health considerations such as bone health, hormonal balance, and overall well-being escalate to increased demand for supplements tailored to meet health needs. For instance, research indicated that hormonal imbalance is prevalent among females, with approximately 80% experiencing it during their lifetime, often beginning during reproductive age.
Similarly, the World Health Organization (WHO) reports that Polycystic ovary syndrome (PCOS) has affected an estimated 8–13% of reproductive-aged women, further contributing to hormonal irregularities. This can be attributed to factors such as poor lifestyle choices, environmental influences, and malfunctioning endocrine glands that causes hormonal imbalances in females.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Womens health supplements market size was USD 41.4 billion in 2023 and is expected to register 5.6% CAGR from 2024-2032 owing to the increasing chronic disorders coupled with growing awareness among women for maintaining their health and well-being worldwide.

The vitamins & minerals segment is expected to register 5.4% CAGR from 2024-2032 due to increasing demand, growing preference for healthy lifestyles, and the rising popularity of preventive healthcare.

North America Womens health supplements industry is expected to record USD 24.6 billion by 2032 due to increased female participation in sports and a growing elderly population in the region.

Bayer AG, Designs for Health, Inc., Dr. Reddy's Laboratories Ltd., Herbalife International of America, Inc., HUM Nutrition, Nutraceutical Corporation, Pfizer, Inc., Procter & Gamble, and Quantum Health., are some of the major women